TipRanks
Insulet (CH:GOV)
:GOV
Switzerland Market
GOV
Insulet
RESEARCH TOOLSreports

Insulet (GOV) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

GOV Analyst Ratings

Moderate Buy
19Ratings
Moderate Buy
10 Buy
9 Hold
0 Sell
Based on 19 analysts giving stock ratings to
Insulet
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GOV Stock 12 Month Forecast

Average Price Target

―
Based on 19 Wall Street analysts offering 12 month price targets for Insulet in the last 3 months. The average price target is CHF136.25 with a high forecast of CHF170.47 and a low forecast of CHF118.02. The average price target represents a ― change from the last price of ―.
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
Highest Price TargetCHF170.47Average Price TargetCHF136.25Lowest Price TargetCHF118.02
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on CH:GOV
Joanne Wuensch
Citi
Citi
CHF122.93
Hold
―
Reiterated
08/13/26
Insulet (PODD) Receives a Hold from Citi
UBS Analyst forecast on CH:GOV
Patrick Wood
UBS
UBS
CHF122.93
Hold
―
Assigned
08/12/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Robert W. Baird Analyst forecast on CH:GOV
Jeff Johnson
Robert W. Baird
Robert W. Baird
CHF203.25→CHF143.42
Buy
―
Reiterated
08/06/26
Insulet price target lowered to $175 from $248 at BairdInsulet price target lowered to $175 from $248 at Baird
Leerink Partners Analyst forecast on CH:GOV
Mike Kratky
Leerink Partners
Leerink Partners
CHF118.84
Hold
―
Downgraded
08/06/26
Insulet downgraded to Market Perform from Outperform at LeerinkInsulet downgraded to Market Perform from Outperform at Leerink
Evercore ISI Analyst forecast on CH:GOV
Daniel Markowitz CFA
Evercore ISI
Evercore ISI
CHF147.52
Buy
―
Reiterated
08/06/26
Analysts Are Bullish on These Healthcare Stocks: Myomo (MYO), CVS Health (CVS)
Truist Financial Analyst forecast on CH:GOV
Richard Newitter
Truist Financial
Truist Financial
CHF172.11→CHF125.39
Hold
―
Downgraded
08/06/26
Insulet downgraded to Hold from Buy at TruistInsulet downgraded to Hold from Buy at Truist
TD Cowen Analyst forecast on CH:GOV
Mathew Blackman
TD Cowen
TD Cowen
CHF240.95→CHF118.02
Hold
―
Assigned
08/06/26
Analysts Offer Insights on Healthcare Companies: Insulet (NASDAQ: PODD), ImageneBio (NASDAQ: IMA) and InMode (NASDAQ: INMD)
Canaccord Genuity Analyst forecast on CH:GOV
William Plovanic
Canaccord Genuity
Canaccord Genuity
CHF204.07→CHF146.7
Buy
―
Reiterated
08/06/26
Insulet price target lowered to $179 from $249 at CanaccordInsulet price target lowered to $179 from $249 at Canaccord
Stifel Nicolaus Analyst forecast on CH:GOV
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
CHF184.4→CHF147.52
Buy
―
Assigned
08/06/26
Stifel Nicolaus Sticks to Its Buy Rating for Insulet (PODD)
Deutsche Bank Analyst forecast on CH:GOV
Kieran Ryan
Deutsche Bank
Deutsche Bank
CHF155.72→CHF147.52
Buy
―
Reiterated
08/06/26
Insulet (PODD) Receives a Buy from Deutsche Bank
Bernstein Analyst forecast on CH:GOV
Lee Hambright
Bernstein
Bernstein
CHF163.91→CHF143.42
Buy
―
Reiterated
08/06/26
Bernstein Remains a Buy on Insulet (PODD)
Benchmark Co. Analyst forecast on CH:GOV
Bruce Jackson
Benchmark Co.
Benchmark Co.
CHF204.89→CHF151.62
Buy
―
Reiterated
08/06/26
Analysts Conflicted on These Healthcare Names: Aurora Cannabis (NASDAQ: ACB), Biodesix (NASDAQ: BDSX) and Insulet (NASDAQ: PODD)
BTIG Analyst forecast on CH:GOV
Marie Thibault
BTIG
BTIG
―
Hold
―
Downgraded
08/06/26
Insulet downgraded to Neutral from Buy at BTIGInsulet downgraded to Neutral from Buy at BTIG
William Blair Analyst forecast on CH:GOV
Steven Lichtman
William Blair
William Blair
―
Buy
―
Reiterated
08/05/26
Analysts' Top Healthcare Picks: Insulet (PODD), Entrada Therapeutics Inc (TRDA)
Oppenheimer Analyst forecast on CH:GOV
Suraj Kalia
Oppenheimer
Oppenheimer
―
Hold
―
Downgraded
08/05/26
Insulet downgraded to Perform from Outperform at OppenheimerInsulet downgraded to Perform from Outperform at Oppenheimer
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Citi Analyst forecast on CH:GOV
Joanne Wuensch
Citi
Citi
CHF122.93
Hold
―
Reiterated
08/13/26
Insulet (PODD) Receives a Hold from Citi
UBS Analyst forecast on CH:GOV
Patrick Wood
UBS
UBS
CHF122.93
Hold
―
Assigned
08/12/26
Wall Street Analysts Are Neutral on Top Healthcare Picks
Robert W. Baird Analyst forecast on CH:GOV
Jeff Johnson
Robert W. Baird
Robert W. Baird
CHF203.25→CHF143.42
Buy
―
Reiterated
08/06/26
Insulet price target lowered to $175 from $248 at BairdInsulet price target lowered to $175 from $248 at Baird
Leerink Partners Analyst forecast on CH:GOV
Mike Kratky
Leerink Partners
Leerink Partners
CHF118.84
Hold
―
Downgraded
08/06/26
Insulet downgraded to Market Perform from Outperform at LeerinkInsulet downgraded to Market Perform from Outperform at Leerink
Evercore ISI Analyst forecast on CH:GOV
Daniel Markowitz CFA
Evercore ISI
Evercore ISI
CHF147.52
Buy
―
Reiterated
08/06/26
Analysts Are Bullish on These Healthcare Stocks: Myomo (MYO), CVS Health (CVS)
Truist Financial Analyst forecast on CH:GOV
Richard Newitter
Truist Financial
Truist Financial
CHF172.11→CHF125.39
Hold
―
Downgraded
08/06/26
Insulet downgraded to Hold from Buy at TruistInsulet downgraded to Hold from Buy at Truist
TD Cowen Analyst forecast on CH:GOV
Mathew Blackman
TD Cowen
TD Cowen
CHF240.95→CHF118.02
Hold
―
Assigned
08/06/26
Analysts Offer Insights on Healthcare Companies: Insulet (NASDAQ: PODD), ImageneBio (NASDAQ: IMA) and InMode (NASDAQ: INMD)
Canaccord Genuity Analyst forecast on CH:GOV
William Plovanic
Canaccord Genuity
Canaccord Genuity
CHF204.07→CHF146.7
Buy
―
Reiterated
08/06/26
Insulet price target lowered to $179 from $249 at CanaccordInsulet price target lowered to $179 from $249 at Canaccord
Stifel Nicolaus Analyst forecast on CH:GOV
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
CHF184.4→CHF147.52
Buy
―
Assigned
08/06/26
Stifel Nicolaus Sticks to Its Buy Rating for Insulet (PODD)
Deutsche Bank Analyst forecast on CH:GOV
Kieran Ryan
Deutsche Bank
Deutsche Bank
CHF155.72→CHF147.52
Buy
―
Reiterated
08/06/26
Insulet (PODD) Receives a Buy from Deutsche Bank
Bernstein Analyst forecast on CH:GOV
Lee Hambright
Bernstein
Bernstein
CHF163.91→CHF143.42
Buy
―
Reiterated
08/06/26
Bernstein Remains a Buy on Insulet (PODD)
Benchmark Co. Analyst forecast on CH:GOV
Bruce Jackson
Benchmark Co.
Benchmark Co.
CHF204.89→CHF151.62
Buy
―
Reiterated
08/06/26
Analysts Conflicted on These Healthcare Names: Aurora Cannabis (NASDAQ: ACB), Biodesix (NASDAQ: BDSX) and Insulet (NASDAQ: PODD)
BTIG Analyst forecast on CH:GOV
Marie Thibault
BTIG
BTIG
―
Hold
―
Downgraded
08/06/26
Insulet downgraded to Neutral from Buy at BTIGInsulet downgraded to Neutral from Buy at BTIG
William Blair Analyst forecast on CH:GOV
Steven Lichtman
William Blair
William Blair
―
Buy
―
Reiterated
08/05/26
Analysts' Top Healthcare Picks: Insulet (PODD), Entrada Therapeutics Inc (TRDA)
Oppenheimer Analyst forecast on CH:GOV
Suraj Kalia
Oppenheimer
Oppenheimer
―
Hold
―
Downgraded
08/05/26
Insulet downgraded to Perform from Outperform at OppenheimerInsulet downgraded to Perform from Outperform at Oppenheimer
Stocks with the Highest Top Analyst Consensus in the General Sector
STDNStandard Nuclear
SKHYSK Hynix
ITGITG Inc. Class A
LIMENeutron Holdings, Inc.
EROCERock
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Insulet

3 Months
Matthew TaylorJefferies
Success Rate
16/19 ratings generated profit
84%
Average Return
+9.54%
Copying Matthew Taylor's trades and holding each position for 3 Months would result in 84.21% of your transactions generating a profit, with an average return of +9.54% per trade.
1 Year
Matthew TaylorJefferies
Success Rate
13/19 ratings generated profit
68%
Average Return
+16.56%
Copying Matthew Taylor's trades and holding each position for 1 Year would result in 68.42% of your transactions generating a profit, with an average return of +16.56% per trade.
2 Years
Jayson BedfordRaymond James
Success Rate
19/31 ratings generated profit
61%
Average Return
+37.83%
Copying Jayson Bedford's trades and holding each position for 2 Years would result in 61.29% of your transactions generating a profit, with an average return of +37.83% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GOV Analyst Recommendation Trends

Rating
May 26
Jun 26
Jul 26
Aug 26
Sep 26
Strong Buy
20
20
16
3
1
Buy
15
21
21
19
12
Hold
5
5
5
13
13
Sell
2
2
2
0
0
Strong Sell
0
0
0
0
0
total
42
48
44
35
26
In the current month, GOV has received 13 Buy Ratings, 13 Hold Ratings, and 0 Sell Ratings. GOV average Analyst price target in the past 3 months is 136.25.
Each month's total comprises the sum of three months' worth of ratings.

GOV Financial Forecast

GOV Earnings Forecast

Next quarter’s earnings estimate for GOV is CHF1.29 with a range of CHF1.24 to CHF1.35. The previous quarter’s EPS was CHF1.35. GOV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year GOV has Performed in-line its overall industry.
Next quarter’s earnings estimate for GOV is CHF1.29 with a range of CHF1.24 to CHF1.35. The previous quarter’s EPS was CHF1.35. GOV beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year GOV has Performed in-line its overall industry.

GOV Sales Forecast

Next quarter’s sales forecast for GOV is CHF677.92M with a range of CHF672.22M to CHF681.79M. The previous quarter’s sales results were CHF652.18M. GOV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year GOV has Performed in-line its overall industry.
Next quarter’s sales forecast for GOV is CHF677.92M with a range of CHF672.22M to CHF681.79M. The previous quarter’s sales results were CHF652.18M. GOV beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year GOV has Performed in-line its overall industry.

GOV Stock Forecast FAQ

What is CH:GOV’s average 12-month price target, according to analysts?
Based on analyst ratings, Insulet’s 12-month average price target is 136.25.
    What is CH:GOV’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for CH:GOV, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is Insulet a Buy, Sell or Hold?
        Insulet has a consensus rating of Moderate Buy, which is based on 10 buy ratings, 9 hold ratings and 0 sell ratings.
          What is Insulet’s share price target?
          The average share price target for Insulet is 136.25. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst share price target is CHF170.47 ,and the lowest forecast is CHF118.02. The average share price target represents N/A Increase from the current price of N/A.
            What do analysts say about Insulet?
            Insulet’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.
              How can I buy shares of Insulet?
              To buy shares of CH:GOV, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.